Looks to be breaking down, page-11

So, hovering around the 38 cent mark again. I wonder if today's update and 4C helped that along (probably did). There was a useful comment in there regarding enrolments DDD (see below - I extracted a portion). GLTA

Upcoming Milestones

• BNC210 Phase 2 PTSD clinical trial enrolment is ongoing and is expected to be completed in quarter 1, CY2018. Data from the clinical trial are anticipated in the second half of CY2018. Details of the trial can be found at its dedicated website https://restoreresearchstudy.com
• In parallel, Bionomics continues to progress potential partnership discussions and the monetisation of non-core assets.